SlidesetHIVInternational Workshop on HIV & Pediatrics 2018Debate: All children should be switched to dolutegravir-based ART regimens PRO- Adeodata Kekitiinwa, MBChB, MMedView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2018Debate: All children should be switched to dolutegravir-based ART regimens CON- Nandita SugandhiView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2018Debate: All children should be switched to dolutegravir-based ART regimensView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2018HIV vaccines and broadly neutralizing monoclonal antibody - role in the cure agenda- Sandhya Vasan, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2018Controllers: post-treatment vs elite controllers – what do we know?- Phillip Goulder, MA, FRCPCH, DPhil, FMedScView Slideset
LMLynne MofensonMDSlidesetHIVInternational Workshop on HIV & Pediatrics 2018Opening Words- Lynne Mofenson, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2018Early treatment and clinical outcomes – does early ART make a difference?- Louise Kuhn, PhDView Slideset
